Ocugen Inc (OCGN) concluded trading on Wednesday at a closing price of $1.17, with 6.72 million shares of worth about $7.87 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 56.06% during that period and on July 23, 2025 the price saw a gain of about 13.59%. Currently the company’s common shares owned by public are about 292.03M shares, out of which, 286.77M shares are available for trading.
Stock saw a price change of 12.50% in past 5 days and over the past one month there was a price change of 19.25%. Year-to-date (YTD), OCGN shares are showing a performance of -29.52% which increased to 45.34% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.51 but also hit the highest price of $1.72 during that period. The average intraday trading volume for Ocugen Inc shares is 5.64 million. The stock is currently trading 12.92% above its 20-day simple moving average (SMA20), while that difference is up 19.96% for SMA50 and it goes to 40.72% higher than SMA200.
Ocugen Inc (NASDAQ: OCGN) currently have 292.03M outstanding shares and institutions hold larger chunk of about 26.35% of that.
The stock has a current market capitalization of $341.67M and its 3Y-monthly beta is at 3.85. It has posted earnings per share of -$0.19 in the same period. It has Quick Ratio of 2.60 while making debt-to-equity ratio of 2.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for OCGN, volatility over the week remained 7.55% while standing at 7.70% over the month.
Stock’s fiscal year EPS is expected to drop by -10.00% while it is estimated to decrease by -9.09% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Maxim Group on October 15, 2024 offering a Buy rating for the stock and assigned a target price of $4 to it. Coverage by Chardan Capital Markets stated Ocugen Inc (OCGN) stock as a Buy in their note to investors on March 01, 2023, suggesting a price target of $3.50 for the stock. On August 23, 2022, Mizuho Initiated their recommendations, while on June 15, 2022, ROTH Capital Resumed their ratings for the stock with a price target of $8. Stock get an Overweight rating from Cantor Fitzgerald on June 02, 2022.
